ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROL

设立癌症预防和控制领域的研究者奖

• 批准号: 8702923
• 负责人: THOMAS L VAUGHAN
• 金额: $ 15.12万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-07-23 至 2017-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8702923
• 关键词: Address; Americas; Anthropometry; Applications Grants; Award; Barrett Esophagus; Barrett' s Adenocarcinoma; Biological Markers; Biology; Biometry; Blood; Calibration; Cancer Control; Caring; Chromosomal Instability; Clinical; Commit; Counseling; Country; Data; Data Set; Development; Discipline; Disease; Education; Educational workshop; Ensure; Environmental Risk Factor; Epidemiology; Esophageal Adenocarcinoma; Etiology; Evaluation; Faculty; Fred Hutchinson Cancer Research Center; Funding; Gap Junctions; Gastroenterology; General Population; Genetic; Genome; Grant; Health Personnel; Health Policy; Incidence; Individual; Inflammation; Institutes; Institution; International; Joints; Journals; Knowledge; Leadership; Length; Malignant Neoplasms; Manuscripts; Measures; Medical Research; Mentors; Modeling; Molecular Biology; National Institute of Diabetes and Digestive and Kidney Diseases; Oxidative Stress; Paper; Participant; Patient Education; Pharmaceutical Preparations; Phase; Physiology; Policy Developments; Population; Population Attributable Risks; Population Genetics; Population Heterogeneity; Postdoctoral Fellow; Prevention; Prevention program; Preventive Intervention; Primary Health Care; Provider; Publishing; Queensland; Research; Research Activity; Research Personnel; Research Project Grants; Resources; Risk; Risk Factors; Role; Running; Secondary to; Senior Scientist Award; Site; Societies; Students; Supervision; Target Populations; Time; Tissues; Training; Trust; Universities; Validation; Visit; Washington; Work; adipokines; anticancer research; base; cancer epidemiology; cancer prevention; clinical decision-making; cost effectiveness; design; directed evolution; experience; genetic epidemiology; genome wide association study; genome-wide; graduate student; insulin sensitivity; interest; lectures; male; meetings; member; population health; pre-doctoral; programs; response; skills; symposium; telomere; tool; tumor progression; wasting

DESCRIPTION (provided by applicant): The K05 award will provide Dr. Thomas L Vaughan with protected time (30% FTE) to continue to pursue key research questions related to the etiology and prevention of esophageal adenocarcinoma (EA), a cancer that has undergone a remarkable increase in incidence (6-fold overall, and 10-fold among white males) in the US and many western countries during the past four decades. It will also provide for protected time (20% FTE) to continue his extensive mentoring activities of students, postdoctoral fellows and junior investigators at the University of Washington (UW), the Fred Hutchinson Cancer Research Center (FHCRC) and outside institutions. The first four years of his current award (July 2007 - October 2011) provided critical protected time for him to focus on further developing and strengthening his research program on EA. Aim 1 of the current award funds his effort on analyses of previously-collected data and biospecimens from local studies with expired funding. This concentrated effort has thus far resulted in 20 published papers, and eight submitted manuscripts, many involving his direct supervision of pre- and postdoctoral mentees. Dr. Vaughan was one of the co-founders of the international Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) in 2005, supported in part by NCI. He was elected as first Steering Committee Chair and continues in that role. Aim 2 of the current award involves establishing BEACON as an important nexus for research on etiology and prevention of EA. During the first four years of the current award, membership in the consortium has approximately doubled, with annual workshops typically involving 40-50 attendees. Additional expertise in clinical gastroenterology, molecular biology, physiology, genetics, evolutionary biology and population genetics has been added to significantly expand the range of expert skill and knowledge available to plan and carry out new studies. Six research projects have been by grants from the NCI, NIDDK, Cancer Research UK, and the Swedish Cancer Society. Over the past two years, a further six manuscripts have been published or submitted and several more are in the final phases of development. Aim 3 of the current award involves development of new collaborative research projects within BEACON. The award allowed Dr. Vaughan to develop a multiple PI grant (funded in late 2009) for a genome-wide association study involving 14 sites and about 8,500 participants. The K05 award was key in providing not only protected time to develop this logistically-complicated grant application, but important training opportunities for Dr. Vaughan in genetic epidemiology (e.g., Welcome Trust conference on genetics of common diseases; invited participation at the Illumina Americas Scientific Summit and as a visiting scholar at Queensland Institute of Medical Research.) Proposed research activities during the renewal period represent a direct evolution of ideas and projects developed during the current K05 award period. The first aim will utilize the rich data resources of BEACON to develop risk and prediction models which are tailored to the absolute risk of specific populations that will be useful for a) health policy development, b) education, c) clinical decision-making, and d) designing future research. This aims address critical barriers to EA control by facilitating improvement in the costs and effectiveness of EA prevention interventions by ensuring that they make optimum use of knowledge regarding risk factors, protective factors and biomarkers that predict neoplastic progression, response to therapy and survival. The second aim encompasses his continued scientific leadership role in BEACON. Specifically this involves developing and actively participating in ongoing and new pooled analyses with the Consortium members, including ongoing BEACON studies such as analysis of telomere length, IGF-related markers, and adipokines; as well as ancillary analyses to the ongoing genome-wide association study of BE and EA. It also involves developing new collaborative research projects with BEACON investigators and mentees that will take advantage of the diverse populations represented, along with existing banks of well-characterized tissues. Dr. Vaughan has a well-established track record of mentoring graduate students and postdoctoral fellows, as well as junior faculty in Epidemiology and related disciplines. He is Director of an NCI-funded Cancer Epidemiology and Biostatistics Training Grant which funds nine predoctoral and four postdoctoral trainees and runs the journal club. He guest lectures in established epidemiology courses, and has served on 29 master's thesis committees, and 26 doctoral dissertation committees. Mentoring activities funded by the K05 will include: i) those associated with his responsibilities on the training grant, ii) his ongoing mentoring of other trainees from Epidemiology and related departments, and iii) mentoring junior faculty at the UW, FHCRC and outside institutions. Each year, he plans to work closely with two to three predoctoral students, one to two postdoctoral fellows; and one to two junior faculty members.

描述（由申请人提供）：K 05奖将为托马斯L Vaughan博士提供受保护的时间（30% FTE），以继续追求与食管腺癌（EA）的病因学和预防相关的关键研究问题，在过去的四十年中，美国和许多西方国家的食管腺癌（EA）的发病率显著增加（总体增加6倍，白色男性增加10倍）。它还将提供受保护的时间（20% FTE），以继续他在华盛顿大学（UW），弗雷德哈钦森癌症研究中心（FHCRC）和外部机构的学生，博士后研究员和初级研究人员的广泛指导活动。 他目前的奖项的前四年（2007年7月至2011年10月）为他提供了关键的保护时间，使他能够专注于进一步发展和加强他的EA研究计划。当前奖项的目标1资助他分析之前收集的数据和来自当地研究的生物标本，资金已到期。到目前为止，这种集中的努力已经发表了20篇论文，8篇提交了手稿，其中许多涉及他对博士前和博士后学员的直接监督。Vaughan博士是2005年国际巴雷特和食管腺癌联盟（BEACON）的联合创始人之一，部分由NCI支持。他当选为第一任指导委员会主席，并继续担任这一职务。本奖项的目标2涉及建立BEACON作为研究EA病因和预防的重要纽带。在目前的奖项的前四年，联盟的成员大约增加了一倍，每年的研讨会通常有40-50名与会者。增加了临床胃肠病学，分子生物学，生理学，遗传学，进化生物学和群体遗传学方面的额外专业知识，以显着扩大规划和开展新研究的专业技能和知识范围。六个研究项目得到了NCI，NIDDK，英国癌症研究和瑞典癌症协会的赠款。在过去两年中，又出版或提交了六份手稿，还有几份处于最后编写阶段。目前奖项的目标3涉及在BEACON内开发新的合作研究项目。该奖项允许Vaughan博士为涉及14个地点和约8，500名参与者的全基因组关联研究开发多个PI赠款（2009年底资助）。K 05奖不仅为开发这一后勤复杂的拨款申请提供了受保护的时间，而且为沃恩博士提供了遗传流行病学方面的重要培训机会（例如，关于常见疾病遗传学的欢迎信托会议;应邀参加Illumina美洲科学峰会，并作为访问学者在昆士兰州医学研究所。 更新期间的拟议研究活动代表了当前K 05奖励期间开发的想法和项目的直接演变。第一个目标将利用BEACON丰富的数据资源，开发风险和预测模型，这些模型针对特定人群的绝对风险，将有助于a）卫生政策制定，B）教育，c） 临床决策; d）设计未来研究。这一目标旨在通过促进EA预防干预措施的成本和有效性的改善来解决EA控制的关键障碍，确保他们最佳利用有关风险因素，保护因素和预测肿瘤进展，治疗反应和生存的生物标志物的知识。第二个目标包括他在BEACON中继续发挥科学领导作用。具体而言，这涉及与联盟成员一起开发并积极参与正在进行的和新的汇总分析，包括正在进行的BEACON研究，如端粒长度分析，IGF相关标志物和脂肪因子;以及正在进行的BE和EA全基因组关联研究的辅助分析。它还涉及与BEACON研究人员和学员开发新的合作研究项目，这些项目将利用所代表的不同人群，沿着现有的特征良好的组织库。 博士沃恩在指导研究生和博士后研究员以及流行病学和相关学科的初级教师方面有着良好的记录。他是NCI资助的癌症流行病学和生物统计学培训补助金的主任，该补助金资助了9名博士前和4名博士后学员，并经营期刊俱乐部。他在流行病学课程中担任客座讲师，并在29个硕士论文委员会和26个博士论文委员会任职。由K 05资助的辅导活动将包括：i）与他在培训补助金上的责任相关的活动，ii）他对流行病学和相关部门的其他学员的持续指导，以及iii）指导UW，FHCRC和外部机构的初级教师。每年，他计划与两到三名博士前学生，一到两名博士后研究员密切合作;和一到两名初级教师。